AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025

Reuters

09/30

AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025

For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2571933312"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2571933312\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2571933312?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-09-30 16:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2571933312","market":"fut","top_or_hot":-1,"title":"AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2025-09-30 16:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01789","symbol_name":"爱康医疗","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250930:nNDL1sDDvb:1","article_id":"2571933312","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2571933312","pubTimestamp":1759221532,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical H","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01789":"爱康医疗","BK1583":"高瓴概念","BK1617":"AI医疗","BK1100":"医疗保健设备","BK1585":"昨日强势股"},"translate_title":"爱康医疗控股报告2025年上半年收入增长5.6%，利润增长15.3%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01789":0.9},"content_text":"AK Medical Holdings Reports 5.6% Rise in Revenue and 15.3% Increase in Profit for H1 2025\n    \n\n        For the six months ended 30 June 2025, the Group reported revenue of RMB694.2 million, an increase of 5.6% compared to RMB657.1 million for the same period in 2024. Gross profit was RMB410.3 million, up 3.0% from RMB398.5 million. Profit for the period was RMB160.6 million, a 15.3% increase from RMB139.3 million in the previous year. Gross margin for the period was 59.1%, compared to 60.6% for the same period in 2024. Cost of sales amounted to RMB283.9 million, up 9.8% from RMB258.6 million. Other income was RMB18.3 million, compared to RMB2.9 million for the same period in 2024. Selling and distribution expenses totaled RMB117.3 million, a 3.8% increase from RMB113.0 million.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AK Medical Holdings Ltd. published the original content used to generate this news brief on September 30, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"executive,dataReport,express","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}